About Egenix

Board Room

Overview
Management
Board of Directors
Corporate Advisors
Scientific Advisors

Corporate Advisors

Michael Patane, PhD – Egenix Therapeutics
  • Former Executive Director, Global Discovery Chemistry, Novartis
  • Former Directory Medicinal Chemistry, Millennium
  • Chief Scientific Officer, EyeGate Pharmaceuticals
  • Advanced more than 15 compounds to pre-clinical and clinical development
 
David Frank, PhD – Egenix Diagnostics
  • 35 years of diagnostics experience at Kodak and Johnson & Johnson
  • Ph.D. Cornell University
  • Background in Business Development, Marketing, and R&D
  • Managing Director, MEDx Associates LLC
 
Lionel Goldfrank III – Financial Advisor
  • Founder American and Overseas Asset Services Corporation
  • Principal in several private investment companies
  • Formerly with Goldman Sachs and Co.
 
David C. Clapp – Financial Advisor
  • Lead Director of MBIA, Inc
  • Chairman of Arthritis Foundation
  • Board member, Bard College, Kent School, and Scenic Hudson Land Trust
  • Former General Partner of Goldman Sachs and Co.
 
W. James Tozer, Jr. – Financial Advisor
  • President and co-founder of the Vectra Management Group
  • Co-founder of Vectra Banking Corporation
  • Former director of LendingTree, Inc.
  • Former President of Prudential Bache Securities